Leveraging the power of technology to create a more patient-centric approach and consolidate costs is expected to play a big role.
Although the cloud offers great value for medtech manufacturers and device users, it also creates new challenges.
Patients will be able to collect their own samples and ship it to a Quest Diagnostics lab for analysis.
It’s time to consider CAPAs as opportunities rather than just other issues to tackle.
The challenge for the digital health community will be to bring the same high standards for care in the physical world to their digital interactions.
The technology behind remote cardiac device monitoring is becoming more convenient, responsive and connected across the digital ecosystem—including a new smartphone app.
The absence of any of these disciplines can lead to blind spots that can introduce risk, but they are not all created equal.
All commercial, clinical, R&D and manufacturing activities surrounding the product will end.
Moving too quickly in the product development process can lead to mistakes.
An upcoming webinar will discuss the new methods and protocols that have emerged as a result of conducting trials and HF studies during the pandemic.